Clinical implications of elevated serum soluble CD137 levels in patients with acute coronary syndrome

Clinics

Volumn 68, Issue 2, 2013, Pages 193-198

  Yan, Jinchuan ^a   Wang, Cuiping ^a   Chen, Rui ^a   Yang, Haibing ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

Acute coronary syndrome; Atherosclerosis; CD137

Indexed keywords

BIOLOGICAL MARKER; CD137 ANTIGEN;

ACUTE CORONARY SYNDROME; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; FEMALE; HUMAN; MALE; MIDDLE AGED; PROGNOSIS; REFERENCE VALUE; RISK ASSESSMENT; THROMBOCYTE ACTIVATION; TIME;

ACUTE CORONARY SYNDROME; AGED; ANALYSIS OF VARIANCE; ANTIGENS, CD137; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; TIME FACTORS;

EID: 84875684578     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2013(02)OA12     Document Type: Article

References (17)

1. Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem. 2007;53(4):552-74.
2. Thygesen K, Alpert JS, White HD, Joint ESC/AACF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007;50(22):2173-95, http://dx.doi.org/10.1016/j.jacc.2007.09.011.
3. Kaul P, Chang WC, Westerhout CM, Graham MM, Armstrong PW. Differences in admission rates and outcomes between men and women presenting to emergency departments with coronary syndromes. Can Med Assoc J. 2007;177(10):1193-9, http://dx.doi.org/10.1503/cmaj. 060711.
4. Bonaca MP, Morrow DA. Defining a role for novel biomarkers in acute coronary syndromes. Clin Chem. 2008;54(9):1424-31, http://dx.doi.org/10.1373/clinchem.2008.105387.
5. Yan JC, Gong J, Chen GH, Liu PJ, Wang CP, Yang P. Evaluation of serum soluble OX40 ligand as a prognostic indicator in acute coronary syndrome patients. Clin Chim Acta. 2010;411(21-22):1662-5, http://dx. doi.org/10.1016/j.cca.2010.06.016.
6. Kavsak PA, Wang XS, Henderson M, Ko DT, MacRae AR, Jaffe AS. PAPP-A as a marker of increased long-term risk in patients with chest pain. Clinical biochemistry. 2009;42(10-11):1012-8, http://dx.doi.org/10. 1016/j.clinbiochem.2009.03.015.
7. Liu PJ, Yan JC, Gong J, Wang CP, Chen GH. Positive correlation between pregnancy-associated plasma protein-A level and OX40 ligand expression in patients with acute coronary syndromes. Biomedicine & Pharmacotherapy. 2011;65(3):193-7, http://dx.doi.org/10.1016/j.biopha. 2010.10.011.
8. Olofsson PS, Soderstrom LA, Wagsater D, Sheikine Y, Ocaya P, Lang F, et al. CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Circulation. 2008;117(10):1292-301, http://dx.doi.org/10.1161/CIRCU LATIONAHA.107.699173.
9. Dongming L, Zuxun L, Liangjie X, Biao W, Ping Y. Enhanced levels of soluble and hmembrane-bound CD137 levels in patients with acute coronary syndromes. Clin Chim Acta. 2010;411(5-6):406-10, http://dx. doi.org/10.1016/j.cca.2009.12.011.
10. Yan J, Gong J, Liu P, Wang C, Chen G. Positive correlation between CD137 expression and complex stenosis morphology in patients with acute coronary syndromes. Clin Chim Acta. 2011;412(11-12):993-98, http://dx.doi.org/10.1016/j.cca.2011.02.038.
11. Jeon HJ, Choi JH, Jung IH, Park JG, Lee MR, Lee MN, et al. CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice. Circulation. 2010;121(9):1124-33, http://dx.doi.org/10.1161/CIRCULATIONAHA.109.882704.
12. Michelson AD, BarnardMR, Krueger LA, Valeri CR, FurmanMI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin-Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation. 2001;104(13):1533-7, http://dx.doi.org/10.1161/hc3801.095588.
13. Gerdes N, Zirlik A. Co-stimulatory molecules in and beyond costimulation-tipping the balance in atherosclerosis? Thromb Haemost. 2011;106(5):804-13, http://dx.doi.org/10.1160/TH11-09-0605.
14. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36(3):959-69.
15. Thygesen K, Alpert JS, White HD. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J. 2007;28(20):2525-38.
16. Karube A, Suzuki J, Haraguchi G, Maejima Y, Saiki H, Kosuge H, et al. Suppression of neointimal hyperplasia after vascular injury by blocking 4-1BB/4-1BB ligand pathway. J Med Dent Sci. 2008;55(2):207-13.
17. Dumitriu IE, Baruah P, Finlayson CJ, Loftus IM, Antunes RF, Lim P, et al. High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome. Circ Res. 2012;110(6):857-69, http://dx.doi.org/10.1161/CIRCRESAHA.111. 261933.